Covered recipient · General Payments record
NOEMI C VARELA ROSARIO
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2018–2024
$10,294.21
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $498.06 | 20 |
| Consulting Fee | $400.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $524.55 | 6 |
| Amgen Inc. | $206.29 | 9 |
| Celgene Corporation | $104.09 | 3 |
| Acerta Pharma LLC | $35.00 | 1 |
| GlaxoSmithKline, LLC. | $28.13 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (21)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $400.00 | 03/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1106271530 | CMS |
| ABBVIE INC. | $9.84 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106271532 | CMS |
| ABBVIE INC. | $7.47 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106271534 | CMS |
| ABBVIE INC. | $57.50 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106271536 | CMS |
| ABBVIE INC. | $40.51 | 11/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106271538 | CMS |
| ABBVIE INC. | $9.23 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106271540 | CMS |
| Amgen Inc. | $8.81 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191860 | CMS |
| Amgen Inc. | $9.01 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191864 | CMS |
| Amgen Inc. | $22.30 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191880 | CMS |
| Amgen Inc. | $95.20 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117708002 | CMS |
| Amgen Inc. | $17.41 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191873 | CMS |
| Amgen Inc. | $7.03 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191868 | CMS |
| Amgen Inc. | $8.20 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191855 | CMS |
| Amgen Inc. | $18.78 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191884 | CMS |
| Amgen Inc. | $19.55 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116191877 | CMS |
| AstraZeneca Pharmaceuticals LP | $35.00 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104756612 | CMS |
| Celgene Corporation | $19.09 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101078700 | CMS |
| Celgene Corporation | $23.94 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101078702 | CMS |
| Celgene Corporation | $61.06 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101078704 | CMS |
| GlaxoSmithKline, LLC. | $15.06 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116652623 | CMS |
| GlaxoSmithKline, LLC. | $13.07 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115780823 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.